V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002282 | 240004968 | 1.79 | 84.5 | Palliative (P) | 2019-06-18 | 2019-06-26 | AML 18 TRIAL | null | N | CYTARABINE | 101256721 |
| 240002283 | 240004969 | 0 | 67.9 | null | 2016-08-17 | 2016-09-02 | Methotrexate intrathecal | 02 | null | METHOTREXATE | 100549582 |
| 240002284 | 240004970 | 1.77 | 99.2 | null | 2016-08-10 | 2016-08-10 | Azacitidine | null | null | AML19 TRIAL | 101789408 |
| 240002285 | 240004971 | 1.68 | 66.3 | null | null | 2017-11-21 | null | N | null | TRIAL UNSPECIFIED | 101013080 |
| 240002286 | 240004972 | 1.62 | 81.8 | 03 | null | 2016-07-19 | null | null | N | AML19 TRIAL | 100875168 |
| 240002287 | 240004973 | 1.6 | 53.9 | null | 2016-11-04 | 2016-11-04 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 101567333 |
| 240002288 | 240004974 | 1.73 | 61.2 | 03 | 2019-01-01 | 2019-01-02 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 101671452 |
| 240002291 | 240004977 | null | null | 03 | 2019-02-21 | 2019-02-22 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 101851072 |
| 240002292 | 240004978 | 1.69 | 83 | null | null | 2019-07-18 | null | 99 | null | METHOTREXATE | 100628748 |
| 240002293 | 240004979 | 1.56 | 52 | null | null | 2017-11-04 | null | N | null | RITUXIMAB | 100321696 |
| 240002294 | 240004980 | null | null | 03 | null | 2017-09-14 | null | 02 | null | RITUXIMAB | 100792389 |
| 240002295 | 240004981 | 1.85 | 44.2 | 03 | 2019-12-30 | 2020-01-27 | Rituximab | 02 | null | RITUXIMAB | 100683065 |
| 240002296 | 240004982 | 1.65 | 75.5 | null | 2016-02-25 | 2016-02-25 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 101785343 |
| 240002303 | 240004989 | 1.68 | 105.4 | null | 2016-10-05 | 2016-10-05 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100169218 |
| 240002304 | 240004990 | null | null | Palliative (P) | null | 2019-07-09 | null | null | N | METHOTREXATE | 101591510 |
| 240002306 | 240004992 | 1.66 | 85.6 | null | null | 2019-06-27 | null | 01 | null | RITUXIMAB | 101002930 |
| 240002307 | 240004993 | 1.77 | 64.45 | Curative (C) | null | 2018-05-06 | null | null | N | AML19 TRIAL | 101536675 |
| 240002310 | 240004996 | 1.67 | 55.1 | null | 2018-03-25 | 2019-04-03 | AML 18 TRIAL | null | null | CYTARABINE | 100045573 |
| 240002311 | 240004997 | 1.73 | 60.8 | Curative (C) | null | 2019-03-01 | null | 02 | null | CHOP R | 101215538 |
| 240002312 | 240004998 | null | null | null | 2019-12-27 | 2019-12-27 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 101083551 |
| 240002313 | 240004999 | 1.78 | 87 | Curative (C) | 2018-06-14 | 2018-12-30 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 100784928 |
| 240002314 | 240005000 | 1.57 | 101 | null | null | 2016-08-01 | null | 02 | null | CHOP R | 100686975 |
| 240002315 | 240005001 | 1.6 | 74.2 | Adjuvant (A) | null | 2019-11-28 | null | 02 | null | CYTARABINE | 100052435 |
| 240002319 | 240005005 | 1.77 | 85 | null | 2021-10-18 | 2021-10-24 | CYTARABINE | null | null | CYTARABINE | 101744469 |
| 240002322 | 240005007 | 1.75 | 79.8 | null | 2017-07-31 | 2017-08-02 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100350481 |
| 240002323 | 240005008 | null | null | null | null | 2020-07-09 | null | null | null | AML18 TRIAL | 101286007 |
| 240002324 | 240005009 | 1.84 | 69 | null | null | 2019-10-12 | null | 02 | null | METHOTREXATE | 100991931 |
| 240002325 | 240005010 | 1.72 | 96 | null | null | 2016-10-21 | null | 02 | null | METHOTREXATE | 100695863 |
| 240002326 | 240005011 | 1.76 | 74 | Curative (C) | null | 2017-04-15 | null | 02 | N | RITUXIMAB | 101104111 |
| 240002328 | 240005012 | 1.89 | 64.4 | null | null | 2019-04-29 | null | null | null | METHOTREXATE | 101252668 |
| 240002331 | 240005014 | 1.7 | 85 | Palliative (P) | null | 2017-06-28 | null | 2 | null | CYTARABINE | 101376472 |
| 240002335 | 240005016 | 1.65 | 64.1 | Curative (C) | null | 2019-12-21 | null | 1 | null | METHOTREXATE | 100603756 |
| 240002337 | 240005018 | 1.79 | 52.4 | Curative (C) | null | 2019-05-20 | null | 02 | null | AZACITIDINE | 101210426 |
| 240002339 | 240005019 | null | null | null | null | 2016-05-29 | AML 18 TRIAL | null | null | HYDROXYCARBAMIDE | 100856369 |
| 240002342 | 240005022 | 1.59 | 54.8 | Adjuvant (A) | 2017-02-21 | 2017-08-10 | Rituximab | 1 | N | RITUXIMAB | 101618208 |
| 240002346 | 240005026 | 1.81 | 49.9 | null | 2019-01-25 | 2019-01-25 | AML 18 TRIAL | null | null | CYTARABINE | 101075734 |
| 240002349 | 240005028 | 1.78 | 79.5 | Disease modification (D) | 2021-10-13 | 2021-10-13 | GEMCITABINE + OXALIPLATIN + RITUXIMAB | 02 | null | BUSULFAN | 101659815 |
| 240002350 | 240005029 | 1.62 | 64.3 | null | null | 2019-09-05 | Cladribine + Rituximab | null | null | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | 101108568 |
| 240002351 | 240005030 | 1.76 | 66.6 | null | 2017-10-19 | 2017-10-19 | Bendamustine + Obinutuzumab | 02 | null | ALL UKALL2011 DEL INT C | 100578083 |
| 240002352 | 240005031 | 1.6 | 25.9 | Palliative (P) | 2018-11-23 | 2018-12-16 | R-GDP | 02 | N | TRANSPLANT CYCLOPHOSPHAMIDE + FLUDARABINE (+/- TBI) | 101831215 |
| 240002353 | 240005032 | 1.72 | 90.9 | Curative (C) | 2019-08-13 | 2019-08-13 | IVOSIDENIB | 02 | N | ALL UKALL2011 MAINTENANCE | 100284066 |
| 240002354 | 240005033 | 1.65 | 57.4 | Curative (C) | 2018-12-15 | 2018-12-19 | IDELALISIB | 2 | null | GEMTUZUMAB OZOGAMICIN | 101399423 |
| 240002355 | 240005034 | 1.79 | 91 | null | 2019-02-09 | 2019-06-30 | AML Interim Guidelines FLAG-Ida | N | null | METHOTREXATE INTRATHECAL | 100796451 |
| 240002356 | 240005035 | 1.53 | 57 | null | 2018-01-12 | 2018-07-10 | AML MyeChild 01 FLA | null | null | ANAGRELIDE | 100222381 |
| 240002357 | 240005036 | 1.61 | 45.3 | null | null | 2021-02-12 | CHLORAMBUCIL + OBINUTUZUMAB | null | null | CYTARABINE HIGH DOSE | 101453016 |
| 240002358 | 240005037 | 1.67 | 91.9 | Curative (C) | null | 2017-07-20 | Trial Unspecified | null | null | RUXOLITINIB | 100700119 |
| 240002359 | 240005038 | 1.69 | 104 | null | null | 2017-06-19 | Imatinib 400mg | null | null | CISPLATIN + GEMCITABINE | 101665986 |
| 240002362 | 240005041 | 1.72 | 0 | Curative (C) | 2019-12-26 | 2020-01-28 | null | 02 | null | RUXOLITINIB | 100107548 |
| 240002363 | 240005042 | 1.65 | 67.05 | 03 | 2016-06-19 | 2016-07-22 | AML Interim Guidelines FLAG-Ida | N | null | AML DOWNS IT CYTARABINE | 101792096 |
| 240002364 | 240005043 | 1.89 | 63.2 | null | null | 2017-09-21 | Venetoclax | null | null | CHLORAMBUCIL + OBINUTUZUMAB | 101268927 |